Platelet-Rich Plasma (PRP) treatments for premature ovarian aging are increasingly being offered to patients who may not understand the lack of research behind it. Dr. Gleicher explains the existing scientific literature behind PRP and CHR's new study. Find out more here: https://goo.gl/vQq1yC